Implantable Shock Absorber for Treatment of Knee Osteoarthritis
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 253 alerts
Get alerted when Policy 253 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of implantable shock absorbers used to treat knee osteoarthritis for Blue Cross Blue Shield of Massachusetts commercial and Medicare Advantage members. The technology is classified as investigational and is not a covered service for the listed products.
A new medical policy was created classifying implantable shock absorbers for treatment of knee osteoarthritis as investigational.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.